Drug intelligence / Profile preview

fumaria officinalis + silymarin

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Fumaria officinalis + silymarin is a combination of two herbal extracts, Fumaria officinalis (commonly known as fumitory) and silymarin (the main active extract from Silybum marianum, or milk thistle). This combination has been studied primarily for its potential benefits in dermatological conditions such as atopic dermatitis (eczema), where it may reduce severity and symptoms due to the antioxidant, anti-inflammatory, and immunomodulatory properties of both components[1][2][3]. Fumaria officinalis contains isoquinoline alkaloids and other phytochemicals with reported immune-modulating effects. Silymarin is a mixture of flavonolignans with established hepatoprotective, antioxidant, anti-inflammatory, and cell-stabilizing activities. Both herbs have also been investigated individually for hepatoprotective effects. The combination is typically formulated as a topical cream or oral supplement in research settings.

02

Targets

ALB (Human serum albumin)

Beyond the preview

Go deeper on fumaria officinalis + silymarin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fumaria officinalis + silymarin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call